Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ment-ILD
NCT07398287Phase 2Recruiting
- Sponsor
- Region Skåne
- Start
- Apr 2026
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of l-Menthol in interstitial lung disease (ILD), sponsored by Region Skåne. Started Apr 2026; status: recruiting.
02
Drugs
l-Menthol
03
Conditions
interstitial lung disease (ILD)
Beyond the preview
Go deeper on NCT07398287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07398287.